Medra Corporation
MDRA · OTC
12/31/2001 | 12/31/2000 | 12/31/1999 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | 18.9% | 77% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 8.7% | 24.2% | 38.8% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 |
| Operating Expenses | -$0 | -$0 | -$0 |
| Operating Income | $0 | $0 | $0 |
| % Margin | 867% | 780.8% | 656.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -868.8% | -796% | -660.4% |
| EPS | -310 | -320 | -250 |
| % Growth | 3.1% | -28% | – |
| EPS Diluted | -310 | -320 | -250 |
| Weighted Avg Shares Out | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -842.1% | -756.4% | -644.5% |